NCT02846311View on ClinicalTrials.gov

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Influenza
Interventions
DEVICE

Flu Test

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT02846311 - Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV | Biotech Hunter | Biotech Hunter